Cypress Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.6M | Sell |
16,657
-224
| -1% | -$21.8K | 0.35% | 59 |
|
|
2025
Q3 | $1.61M | Sell |
16,881
-67
| -0.4% | -$6.16K | 0.37% | 57 |
|
|
2025
Q2 | $1.48M | Sell |
16,948
-78
| -0.5% | -$6.62K | 0.36% | 54 |
|
|
2025
Q1 | $1.53M | Sell |
17,026
-502
| -3% | -$44.9K | 0.41% | 52 |
|
|
2024
Q4 | $1.41M | Sell |
17,528
-145
| -0.8% | -$12.6K | 0.35% | 59 |
|
|
2024
Q3 | $1.59M | Sell |
17,673
-175
| -1% | -$14.7K | 0.4% | 55 |
|
|
2024
Q2 | $1.41M | Sell |
17,848
-2,768
| -13% | -$227K | 0.36% | 59 |
|
|
2024
Q1 | $1.8M | Sell |
20,616
-200
| -1% | -$17.1K | 0.49% | 55 |
|
|
2023
Q4 | $1.71M | Sell |
20,816
-2,363
| -10% | -$180K | 0.52% | 55 |
|
|
2023
Q3 | $1.82M | Sell |
23,179
-917
| -4% | -$76.8K | 0.61% | 49 |
|
|
2023
Q2 | $2.12M | Sell |
24,096
-400
| -2% | -$34.4K | 0.68% | 46 |
|
|
2023
Q1 | $1.97M | Sell |
24,496
-520
| -2% | -$42.4K | 0.68% | 48 |
|
|
2022
Q4 | $1.94M | Sell |
25,016
-2,820
| -10% | -$229K | 0.71% | 48 |
|
|
2022
Q3 | $2.25M | Sell |
27,836
-315
| -1% | -$28.3K | 0.86% | 38 |
|
|
2022
Q2 | $2.53M | Sell |
28,151
-1,250
| -4% | -$127K | 0.9% | 38 |
|
|
2022
Q1 | $3.26M | Sell |
29,401
-3,490
| -11% | -$369K | 0.96% | 34 |
|
|
2021
Q4 | $3.4M | Sell |
32,891
-129
| -0.4% | -$14.9K | 0.81% | 40 |
|
|
2021
Q3 | $4.14M | Buy |
33,020
+280
| +0.9% | +$36.2K | 1.07% | 28 |
|
|
2021
Q2 | $4.06M | Sell |
32,740
-55
| -0.2% | -$6.91K | 1.04% | 29 |
|
|
2021
Q1 | $3.87M | Sell |
32,795
-160
| -0.5% | -$18.8K | 1.07% | 27 |
|
|
2020
Q4 | $3.86M | Sell |
32,955
-355
| -1% | -$39.1K | 1.08% | 26 |
|
|
2020
Q3 | $3.46M | Buy |
33,310
+9,041
| +37% | +$908K | 1.08% | 30 |
|
|
2020
Q2 | $2.23M | Buy |
24,269
+620
| +3% | +$59.5K | 0.74% | 47 |
|
|
2020
Q1 | $2.13M | Buy |
23,649
+350
| +2% | +$37.2K | 0.92% | 35 |
|
|
2019
Q4 | $2.64M | Buy |
23,299
+2,024
| +10% | +$222K | 0.9% | 34 |
|
|
2019
Q3 | $2.31M | Buy |
21,275
+425
| +2% | +$44.3K | 0.8% | 40 |
|
|
2019
Q2 | $2.03M | Sell |
20,850
-275
| -1% | -$25.1K | 0.69% | 49 |
|
|
2019
Q1 | $1.92M | Sell |
21,125
-155
| -0.7% | -$13.9K | 0.65% | 52 |
|
|
2018
Q4 | $1.94M | Sell |
21,280
-400
| -2% | -$37.4K | 0.72% | 44 |
|
|
2018
Q3 | $2.13M | Buy |
21,680
+695
| +3% | +$64.3K | 0.63% | 53 |
|
|
2018
Q2 | $1.8M | Sell |
20,985
-2,280
| -10% | -$190K | 0.53% | 60 |
|
|
2018
Q1 | $1.87M | Sell |
23,265
-2,555
| -10% | -$211K | 0.55% | 62 |
|
|
2017
Q4 | $2.08M | Sell |
25,820
-340
| -1% | -$27.2K | 0.45% | 63 |
|
|
2017
Q3 | $2.03M | Sell |
26,160
-625
| -2% | -$51.9K | 0.44% | 70 |
|
|
2017
Q2 | $2.38M | Buy |
26,785
+16,750
| +167% | +$1.41M | 0.49% | 61 |
|
|
2017
Q1 | $808K | Sell |
10,035
-110
| -1% | -$8.59K | 0.15% | 120 |
|
|
2016
Q4 | $723K | Buy |
10,145
+975
| +11% | +$76.6K | 0.14% | 126 |
|
|
2016
Q3 | $792K | Sell |
9,170
-175
| -2% | -$15.2K | 0.16% | 120 |
|
|
2016
Q2 | $811K | Buy |
9,345
+350
| +4% | +$28.3K | 0.16% | 122 |
|
|
2016
Q1 | $675K | Buy |
8,995
+300
| +3% | +$22.6K | 0.14% | 124 |
|
|
2015
Q4 | $669K | Buy |
8,695
+180
| +2% | +$13.6K | 0.13% | 125 |
|
|
2015
Q3 | $570K | Sell |
8,515
-210
| -2% | -$15.5K | 0.12% | 125 |
|
|
2015
Q2 | $647K | Buy |
8,725
+460
| +6% | +$35.1K | 0.12% | 126 |
|
|
2015
Q1 | $645K | Buy |
8,265
+200
| +2% | +$15.2K | 0.12% | 124 |
|
|
2014
Q4 | $582K | Buy |
+8,065
| New | +$560K | 0.11% | 128 |
|
Other funds holding MDT
Cypress Asset Management's MDT Position: Q4 2025 in Review
Cypress Asset Management reduced its Medtronic (MDT) stake by 1.3% in Q4 2025, selling an estimated $21.8K and leaving 16,657 shares worth $1.6M. The position accounts for 0.35% of the portfolio, ranked #59.
Cypress Asset Management first reported a position in MDT in Q4 2014 and has held it in 45 quarters since. The position peaked at $4.14M in Q3 2021. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- Cypress Asset Management held 16,657 shares of Medtronic worth $1.6M as of Q4 2025.
- Cypress Asset Management sold 224 Medtronic shares in Q4 2025, an estimated $21.8K.
- Medtronic made up 0.35% of Cypress Asset Management's portfolio in Q4 2025, its #59 holding.
- Cypress Asset Management first reported a position in Medtronic in Q4 2014 and has held it in 45 quarters since.
- Cypress Asset Management's Medtronic position peaked at $4.14M in Q3 2021.
- 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.